LP247822-2
Meropenem+Vaborbactam
Active
Description
Vaborbactam is a beta-lactamase inhibitor in the new cyclic boronic acid class of inhibitors that is being developed in combination with meropenem. It has activity against serine carbapenemases, especially Klebsiella pneumonia carbapenemase (KPC), and the meropenem-vaborbactam combination is effective against KPC-producing strains of Enterobacteriaceae. It has been studied as a treatment of complicated urinary tract infection, acute pyelonephritis, and other infections due to carbapenem-resistant Enterobacteriaceae, including hospital-acquired and ventilator-associated pneumonia PMID: 27527080 In August 2017, meropenem-vaborbactam was approved by the U.S. FDA for the treatment of complicated urinary tract infections, including pyelonephritis. Source: Regenstrief LOINC
Basic Part Properties
- Part Display Name
- Meropenem+Vaborbactam
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2017-01-12
- Construct for LOINC Short Name
- Mero+Vab
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP247822-2
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| es-ES | Spanish (Spain) | Meropenem+Vaborbactam |
| zh-CN | Chinese (China) | 美罗培南+伐波巴坦 Synonyms: 美罗培南（美洛培南）+伐波巴坦（Vaborbactam、 |
| it-IT | Italian (Italy) | Meropenem+Vaborbactam |
| nl-NL | Dutch (Netherlands) | meropenem + vaborbactam |
| fr-CA | French (Canada) | Méropénem+Vaborbactam |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright